SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15845564
Source:
http://linkedlifedata.com/resource/pubmed/id/15845564
Search
Subject
(
53
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0001792
,
umls-concept:C0009566
,
umls-concept:C0030705
,
umls-concept:C0205420
,
umls-concept:C0246415
,
umls-concept:C0278996
,
umls-concept:C0332174
,
umls-concept:C0920321
,
umls-concept:C1522449
pubmed:issue
4
pubmed:dateCreated
2005-4-22
pubmed:abstractText
We planned a phase I study of radiotherapy combined with weekly docetaxel for elderly patients or patients with complications to find out the optimal dose.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0313225
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Phytogenic
,
http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0368-2811
pubmed:author
pubmed-author:FurutaniKazuhisaK
,
pubmed-author:FuwaNobukazuN
,
pubmed-author:KodairaTakeshiT
,
pubmed-author:TachibanaHiroyukiH
,
pubmed-author:YamazakiTakuyaT
pubmed:issnType
Print
pubmed:volume
35
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
173-6
pubmed:meshHeading
pubmed-meshheading:15845564-Aged
,
pubmed-meshheading:15845564-Aged, 80 and over
,
pubmed-meshheading:15845564-Antineoplastic Agents, Phytogenic
,
pubmed-meshheading:15845564-Carcinoma, Squamous Cell
,
pubmed-meshheading:15845564-Combined Modality Therapy
,
pubmed-meshheading:15845564-Dose Fractionation
,
pubmed-meshheading:15845564-Drug Administration Schedule
,
pubmed-meshheading:15845564-Female
,
pubmed-meshheading:15845564-Head and Neck Neoplasms
,
pubmed-meshheading:15845564-Humans
,
pubmed-meshheading:15845564-Leukopenia
,
pubmed-meshheading:15845564-Male
,
pubmed-meshheading:15845564-Maximum Tolerated Dose
,
pubmed-meshheading:15845564-Middle Aged
,
pubmed-meshheading:15845564-Paclitaxel
,
pubmed-meshheading:15845564-Prospective Studies
pubmed:year
2005
pubmed:articleTitle
Phase I trial of weekly docetaxel and concurrent radiotherapy for head and neck cancer in elderly patients or patients with complications.
pubmed:affiliation
Department of Therapeutic Radiation Oncology, Aichi Cancer Center, Chikusa-ku, 464-8681 Nagoya, Aichi, Japan. 109103@aichi-cc.jp
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Clinical Trial, Phase I